Combination Angiotensin‐Receptor Blocker (ARB)/Calcium Channel Blocker With HCTZ vs the Maximal Recommended Dose of an ARB With HCTZ in Patients With Stage 2 Hypertension: The Exforge As Compared to Losartan Treatment in Stage 2 Systolic Hypertension (EXALT) Study

J Clin Hypertens (Greenwich). 2011;13:588–597. This study compared the efficacy and safety of combination angiotensin‐receptor blocker (ARB)/calcium‐channel blocker (CCB) with hydrochlorothiazide (valsartan/amlodipine/HCTZ 160/5/25 mg) vs maximal available combination doses of an ARB with HCTZ (losa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Hypertens (Greenwich)
Main Authors: Wright, Richard F., Duprez, Daniel, Purkayastha, Das, Samuel, Rita, Ferdinand, Keith C.
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2011
Assuntos:
Original Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8108754/
https://ncbi.nlm.nih.gov/pubmed/21806769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2011.00492.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados